Predoc seems like one of the few AI healthcare companies that is actually building something useful.
Trying to get a second opinion and a major academic hospital is messaging me to bring a CD of MRI images for the first appointment because they didn't receive them all......dah f*uck, a CD. I can't even use a USB in my computer anymore.
At least I live near a record store. I can pop in and buy an old Brittany Spears CD. Burn the MRI images as new tracks right after "Baby One More Time."
Chart retrieval is an extremely painful process - but what if it didn't have to be?
Today's post we go through what the process of chart retrieval actually looks like today and where are some critical places it gets used
Then we talk about the engine our sponsoring partner Predoc has built to make this process easier - including using AI agents to chase down your charts from other doctors
This is as unsexy of a back-office problem as it gets, but every provider knows the pain. And there are some nifty ways that AI can help orchestrate all this together.
#JPMHealthcare was last week and everyone the talk was about US being competitive with China / pharma deals with bio foundation models, etc etc, which is all great BUT no one is talking the lack of style in the pharma/biotech world….
Take a look at Pat Riley while coaching basketball. Yelling at refs, jumping up and down, probably profusely sweating. Yet looking fly as f**ck.
Meanwhile, pharma CEOs looking like they made a pit stop at Men’s Warehouse to buy the $20 dress shirt on sale before jumping on stage to talk about how their $300B market cap companies are developing life changing medications touching millions of lives.
Someone help these guys.
WSJ article today today that captures the truth for biotech in both boston and SF at the moment — US is losing the biotech startup industry to China.
If we want to stop this we need two things:
(1) regulatory overhaul as captured well by Bob Nelson here so Ph1 trials are as fast and cheap as in China
https://t.co/OhzkLMbQM8
(2) Autonomous labs so US scientists are competing with Chinese scientists on who has the best ideas — not who has the most hands at the lab bench
https://t.co/tOEbp12nPk
Happy to hear others’ ideas if you’ve got them.
Here’s the article
https://t.co/evLSiTDjqJ
Did some AFM in grad school, the technique was a bitch... at least for adipocytes, but super cool to see mechanobiology being translated into diagnostics!
Exclusive: Boston startup Cellens pulled in $6.5M to develop a new bladder cancer test that reads the physical properties of cells. https://t.co/M23G7MjAa3
We believe this is the first documented case of a large-scale AI cyberattack executed without substantial human intervention. It has significant implications for cybersecurity in the age of AI agents.
Read more: https://t.co/VxqERnPQRJ
@somnivm_@patrick_oshag Exactly, the lack of cross reference between chats is frustrating. Have you tried ChatGPT’s project function yet? Just found out they have something similar to Clause and given ChatGPT’s cross reference abilities I’m wondering if the functionality is better…?
@shelbynewsad Check out CuriMeta & NashBio who look to capitalize on their RWD and Vanderbilt's biobank (BioVU). Also, Biomakers who has the largest tumor biobank in LatAm, happy to chat some more!
@pranamanam Really cool! Also some really interesting applications to biomining...extracting critical minerals (ie copper, lithium, REEs) more sustainably. There has been some interesting work on a new lanmodulin dimer with enhanced rare-earth separation. https://t.co/47Btm0rImM
We at @SVLATAMCap are hosting a trail run this Wednesday followed by a casual dinner. Come connect with fellow entrepreneurs and others from the startup community in the Presidio of San Francisco! Register with the link below. #run#presidio#startups
https://t.co/3ZsSosAcwn